Education
About Us
Working with TipRanks
Follow Us
Renalytix (RNLXY)
OTHER OTC:RNLXY
RNLXY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.12 - $0.94
Previous CloseN/A
Volume36.17K
Average Volume (3M)45.97K
Market Cap
$36.88M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)255.00K
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Jun 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding165,603,010
10 Day Avg. Volume65,340
30 Day Avg. Volume45,973
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Renalytix News
PremiumCompany Announcements
Renalytix AI Plc ADR Earnings Call: FDA Approval and Growth Prospects
PremiumCompany Announcements
Renalytix AI Plc ADR Reports Strong Growth and Strategic Progress---
Ownership Overview
21.14% Insiders
0.03% Mutual Funds
0.02% Other Institutional Investors
78.84% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RNLXY FAQ
What was Renalytix’s price range in the past 12 months?
Renalytix lowest stock price was $0.12 and its highest was $0.94 in the past 12 months.
What is Renalytix’s market cap?
Renalytix’s market cap is $36.88M.
When is Renalytix’s upcoming earnings report date?
Renalytix’s upcoming earnings report date is Jun 17, 2025 which is in 73 days.
How were Renalytix’s earnings last quarter?
Renalytix released its earnings results on Mar 18, 2025. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.1.
Is Renalytix overvalued?
According to Wall Street analysts Renalytix’s price is currently Overvalued.
Does Renalytix pay dividends?
Renalytix does not currently pay dividends.
What is Renalytix’s EPS estimate?
Renalytix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Renalytix have?
Renalytix has 165,603,010 shares outstanding.
What happened to Renalytix’s price movement after its last earnings report?
Renalytix reported an EPS of -$0.1 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 20%.
Which hedge fund is a major shareholder of Renalytix?
Among the largest hedge funds holding Renalytix’s share is Gilder Gagnon Howe & Co LLC.. It holds Renalytix’s shares valued at 0.
---
Company Description
Renalytix
Renalytix (RNLXY) is a healthcare technology company focused on developing and commercializing diagnostic solutions for kidney disease. The company operates within the biotechnology and medical device sectors, offering innovative products and services designed to improve kidney health management and patient outcomes. Renalytix combines advanced diagnostics with machine learning to provide actionable insights for healthcare providers, aiming to enhance the early detection and treatment of kidney disease.
---
RNLXY Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlights significant achievements such as FDA approval, Medicare reimbursement, and strong revenue growth forecasts. However, challenges remain in scaling operations and international expansion.Read More>---
RNLXY Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering RNLXY
1 Year
1 Year Success Rate
1/17 ratings generated profit
1 Year Average Return
-63.07%
reiterated a buy rating 11 months ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 5.88% of your transactions generating a profit, with an average return of -63.07% per trade.
---